Join to View Full Profile
Tennessee Oncology121 Bear Crossing Suite 200Mount Juliet, TN 37122
Phone+1 615-871-9996
Fax+1 615-871-9661
Dr. Nunnery is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Sara Nunnery, MD, is a highly qualified Oncology specialist, with a subspecialty in Breast Cancer, based in Nashville, TN. Her educational journey includes a Residency in Internal Medicine at University of California, a Fellowship in Hematology and Medical Oncology at Vanderbilt University Medical Center, a medical degree from the University of Tennessee Health Science Center College of Medicine, and a Master of Science in Clinical Investigation from Vanderbilt University. Currently, she's employed as an Assistant Professor at Vanderbilt Ingram Cancer Center. Dr. Nunnery's contributions to medical research are significant, with several publications in renowned journals and a number of citations. She is a recipient of the Vanderbilt T32 Integrated Molecular Oncology Research Training Program award.
Education & Training
Vanderbilt UniversityMS, Master of Science in Clinical Investigation, 2020 - 2022
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
University of California (San Francisco)Residency, Internal Medicine, 2017 - 2019
University of Tennessee Health Science Center College of MedicineClass of 2016
Certifications & Licensure
TN State Medical License 2019 - 2026
CA State Medical License 2018 - 2020
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Vanderbilt T32 Integrated Molecular Oncology Research Training Program
Publications & Presentations
PubMed
- 3 citationsPeripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast Cancer.Margaret L Axelrod, Yu Wang, Yaomin Xu, Xiaopeng Sun, Cosmin A Bejan
Cancer Research Communications. 2022-05-01 - 7 citationsTriple-Negative Breast Cancer: Breast Tumors With an Identity Crisis.Sara E Nunnery, Ingrid A. Mayer, Justin M. Balko
Cancer Journal. 2021-01-01 - 96 citationsTargeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast CancerSara E Nunnery, Ingrid A. Mayer
Drugs. 2020-09-07
Grant Support
- Vanderbilt Integrated Molecular Oncology Research Training Program (VIMORTP)Vanderbilt University Medical Center2020–2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
